Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383(11):1050–6. https://doi.org/10.1056/NEJMra1917069.
Article CAS PubMed Google Scholar
Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2024;10(1):11. https://doi.org/10.1038/s41572-024-00495-0.
Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet. 2020;395(10222):450–62. https://doi.org/10.1016/S0140-6736(19)33004-1.
Article PubMed PubMed Central Google Scholar
Li L, Coghill D, Sjolander A, Yao H, Zhang L, Kuja-Halkola R, et al. Increased prescribing of attention-deficit/hyperactivity disorder medication and real-world outcomes over time. JAMA Psychiatr. 2025. https://doi.org/10.1001/jamapsychiatry.2025.1281.
Rising JP, Califf RM. Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response. JAMA Psychiatr. 2025;82(5):436–7. https://doi.org/10.1001/jamapsychiatry.2025.0099.
IQVIA Government Solutions I. Stimulant Prescription Trends in the United States From 2012-20222023 August 31, 2023.
Clemow DB, Walker DJ. The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med. 2014;126(5):64–81. https://doi.org/10.3810/pgm.2014.09.2801.
Palamar JJ, Le A. Discordant reporting of nonmedical amphetamine use among Adderall-using high school seniors in the US. Drug Alcohol Depend. 2017;181:208–12. https://doi.org/10.1016/j.drugalcdep.2017.09.033.
Article PubMed PubMed Central Google Scholar
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31. https://doi.org/10.1097/chi.0b013e31815a56f1.
Administration SAaMHS. Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. In: Center for Behavioral Health Statistics and Quality SAaMHSA, editor.2024.
Volkow ND, Swanson JM. Clinical practice: adult attention deficit-hyperactivity disorder. N Engl J Med. 2013;369(20):1935–44. https://doi.org/10.1056/NEJMcp1212625.
Article CAS PubMed PubMed Central Google Scholar
Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016;27(4):1281–386. https://doi.org/10.1007/s00198-015-3440-3.
Article CAS PubMed PubMed Central Google Scholar
Khosla S, Drake MT, Volkman TL, Thicke BS, Achenbach SJ, Atkinson EJ, et al. Sympathetic beta1-adrenergic signaling contributes to regulation of human bone metabolism. J Clin Investig. 2018;128(11):4832–42. https://doi.org/10.1172/JCI122151.
Article PubMed PubMed Central Google Scholar
Rice JN, Gillett CB, Malas NM. The impact of psychotropic medications on bone health in youth. Curr Psychiatry Rep. 2018;20(11):104. https://doi.org/10.1007/s11920-018-0960-5.
State-based. Prevalence of ADHD Diagnosis and Treatment 2016–2019. Volume 23. Centers for Disease C; 2024.
Xu G, Strathearn L, Liu B, Yang B, Bao W. Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997–2016. JAMA Netw Open. 2018;1(4):e181471. https://doi.org/10.1001/jamanetworkopen.2018.1471.
Article PubMed PubMed Central Google Scholar
Danielson ML, Claussen AH, Bitsko RH, Katz SM, Newsome K, Blumberg SJ, et al. ADHD prevalence among U.S. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment. J Clin Child Adolesc Psychol. 2024;53(3):343–60. https://doi.org/10.1080/15374416.2024.2335625.
Article PubMed PubMed Central Google Scholar
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–23. https://doi.org/10.1176/ajp.2006.163.4.716.
Article PubMed PubMed Central Google Scholar
Survey finds. 25% of adults suspect they have undiagnoses ADHD. Columbus, Ohio.
Gross MD. Origin of stimulant use for treatment of attention deficit disorder. Am J Psychiatry. 1995;152(2):298–9. https://doi.org/10.1176/ajp.152.2.298b.
Article CAS PubMed Google Scholar
Danielson ML, Bitsko RH, Ghandour RM, Holbrook JR, Kogan MD, Blumberg SJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol. 2018;47(2):199–212. https://doi.org/10.1080/15374416.2017.1417860.
Article PubMed PubMed Central Google Scholar
DeFroda SF, Quinn M, Yang DS, Daniels AH, Owens BD. The effects of methylphenidate on stress fractures in patients’ ages 10–29: a national database study. Phys Sportsmed. 2020;48(4):412–6. https://doi.org/10.1080/00913847.2020.1725400.
Faraone SV, Rostain AL, Montano CB, Mason O, Antshel KM, Newcorn JH. Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies. J Am Acad Child Adolesc Psychiatry. 2020;59(1):100–12. https://doi.org/10.1016/j.jaac.2019.06.012.
Harstad E, Shults J, Barbaresi W, Bax A, Cacia J, Deavenport-Saman A, et al. α2-Adrenergic agonists or stimulants for preschool-age children with attention-deficit/hyperactivity disorder. JAMA. 2021;325(20):2067–75. https://doi.org/10.1001/jama.2021.6118.
Article CAS PubMed PubMed Central Google Scholar
Poulton A, Briody J, McCorquodale T, Melzer E, Herrmann M, Baur LA, et al. Weight loss on stimulant medication: how does it affect body composition and bone metabolism? - a prospective longitudinal study. Int J Pediatr Endocrinol. 2012;2012(1):30. https://doi.org/10.1186/1687-9856-2012-30.
Article PubMed PubMed Central Google Scholar
Waxmonsky JG, Pelham WE, Baweja R, Hale D, Pelham WE. Predictors of changes in height, weight, and body mass index after initiation of central nervous system stimulants in children with attention deficit hyperactivity disorder. J Pediatr. 2022;241:115–25. https://doi.org/10.1016/j.jpeds.2021.09.030.
Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD. N Engl J Med. 2019;380(12):1128–38. https://doi.org/10.1056/NEJMoa1813751.
Article CAS PubMed PubMed Central Google Scholar
Ziv-Baran T, Zacay G, Modan-Moses D, Reingold SM, Mekori E, Levy-Shraga Y. Increased fracture risk among children diagnosed with attention- deficit/hyperactivity disorder: a large matched cohort study. Eur J Pediatr. 2023;182(6):2705–14. https://doi.org/10.1007/s00431-023-04929-x.
Takeda S, Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone. 2008;42(5):837–40. https://doi.org/10.1016/j.bone.2008.01.005.
Article CAS PubMed Google Scholar
Dimitri P, Rosen C. The central nervous system and bone metabolism: an evolving story. Calcif Tissue Int. 2017;100(5):476–85. https://doi.org/10.1007/s00223-016-0179-6.
Article CAS PubMed Google Scholar
Hirai T. Regulation of clock genes by adrenergic receptor signaling in osteoblasts. Neurochem Res. 2018;43(1):129–35. https://doi.org/10.1007/s11064-017-2365-y.
Article CAS PubMed Google Scholar
Swanson CM. Sleep Disorders and Osteoporosis. In: Dempster DW, Cauley JA, Bouxsein ML, Cosman F, editors. Marcus and Feldman’s Osteoporosis. 5th Edition ed.: Elsevier: Academic Press; 2021. pp. 1459-71.
Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005;434(7032):514–20. https://doi.org/10.1038/nature03398.
Comments (0)